Serum piperacillin/tazobactam pharmacokinetics in a morbidly obese individual
D Newman, MH Scheetz, OA Adeyemi… - Annals of …, 2007 - journals.sagepub.com
Objective: To report pharmacokinetic alterations and optimal dosing of piperacillin/
tazobactam in an obese patient. Case Summary: A 39-year-old morbidly obese (weight 167 …
tazobactam in an obese patient. Case Summary: A 39-year-old morbidly obese (weight 167 …
Serum piperacillin/tazobactam pharmacokinetics in a morbidly obese individual.
D Newman, MH Scheetz, OA Adeyemi… - The Annals of …, 2007 - europepmc.org
Discussion Substantial differences were noted in both the absolute values at the times of
sample collection and the overall concentration-versus-time profile of both compounds. The …
sample collection and the overall concentration-versus-time profile of both compounds. The …
[引用][C] Serum piperacillin/tazobactam pharmacokinetics in a morbidly obese individual
D NEWMAN, MH SCHEETZ… - The Annals of …, 2007 - pascal-francis.inist.fr
Serum piperacillin/tazobactam pharmacokinetics in a morbidly obese individual CNRS Inist
Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search Advanced …
Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search Advanced …
[PDF][PDF] Serum Piperacillin/Tazobactam Pharmacokinetics in a Morbidly Obese Individual
D Newman, MH Scheetz, OA Adeyemi… - The Annals of …, 2007 - academia.edu
OBJECTIVE: To report pharmacokinetic alterations and optimal dosing of piperacillin/
tazobactam in an obese patient. CASE SUMMARY: A 39-year-old morbidly obese (weight …
tazobactam in an obese patient. CASE SUMMARY: A 39-year-old morbidly obese (weight …
[PDF][PDF] Serum Piperacillin/Tazobactam Pharmacokinetics in a Morbidly Obese Individual
D Newman, MH Scheetz, OA Adeyemi… - The Annals of …, 2007 - researchgate.net
OBJECTIVE: To report pharmacokinetic alterations and optimal dosing of piperacillin/
tazobactam in an obese patient. CASE SUMMARY: A 39-year-old morbidly obese (weight …
tazobactam in an obese patient. CASE SUMMARY: A 39-year-old morbidly obese (weight …
Serum piperacillin/tazobactam pharmacokinetics in a morbidly obese individual
D Newman, MH Scheetz… - The Annals of …, 2007 - pubmed.ncbi.nlm.nih.gov
Objective To report pharmacokinetic alterations and optimal dosing of piperacillin/
tazobactam in an obese patient. Case summary A 39-year-old morbidly obese (weight 167 …
tazobactam in an obese patient. Case summary A 39-year-old morbidly obese (weight 167 …
Serum piperacillin/tazobactam pharmacokinetics in a morbidly obese individual
D Newman, MH Scheetz… - Annals of …, 2007 - scholars.northwestern.edu
OBJECTIVE: TO report pharmacokinetic alterations and optimal dosing of piperacillin/
tazobactam in an obese patient CASE SUMMARY: A 39-year-old morbidly obese (weight …
tazobactam in an obese patient CASE SUMMARY: A 39-year-old morbidly obese (weight …